Welcome to the Competence Center Personalized Medicine in Zurich

DNA Sequencing has changed biomedical research. Now focus is on Medicine: Routine genetic analysis shall make patient-tailored therapies standard. With the new Competence Center Personalized Medicine the University Zurich and ETH Zurich aim for taking a leadership role in the field of Personalized Medicine.

Z-Met: The Zurich Metastasis Project

Metastases are the most common cause of cancer-related death. The Z-Met project is a collaborative effort among clinicians, basic biomedical researchers, and computational scientists to understand how the genomic heterogeneity of tumors drives cancer progression, metastasis formation, and therapeutic resistance. The project encompasses several cancer types, including melanoma, renal cell carcinoma, prostate, breast, and pancreatic cancer, and it involves the development and application of cutting edge technologies, such as single-cell genomics, genome engineering, and computational methods for large-scale clinical and genomic data integration. Patients will benefit from Z-Met not only through novel insights that lead to improved treatment in the future, but also through direct use of the genomic data for treatment decisions in the molecular tumor board. Z-Met aims at generating a unique data set that will be shared among researchers to decipher the genomic basis of metastasis formation and treatment response.


  • The event took place on Friday, 3rd March 2017, 14:00 - 18:45 at UZH (main building, KOL-F-118).

    More …

  • Deadline for submission of project proposals: May 1, 2017.

    More …

  • The Clinical Bioinformatics Unit had their first user meeting on March 1 at the ETH Hoenggerberg Campus (HPL J34).

    More …